These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25747437)

  • 1. Recent progress in the identification and development of anti-malarial agents using virtual screening based approaches.
    Shah P; Tiwari S; Siddiqi MI
    Comb Chem High Throughput Screen; 2015; 18(3):257-68. PubMed ID: 25747437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The state of the art in anti-malarial drug discovery and development.
    Burrows JN; Chibale K; Wells TN
    Curr Top Med Chem; 2011; 11(10):1226-54. PubMed ID: 21401508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Discovery and Development of Antimalarial Agents: Recent Advances.
    Thota S; Yerra R
    Curr Protein Pept Sci; 2016; 17(3):275-9. PubMed ID: 26796302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of anti-malarial agents through application of in silico studies.
    Barmade MA; Murumkar PR; Sharma MK; Shingala KP; Giridhar RR; Yadav MR
    Comb Chem High Throughput Screen; 2015; 18(2):151-87. PubMed ID: 25543680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring anti-malarial potential of FDA approved drugs: an in silico approach.
    Ramakrishnan G; Chandra N; Srinivasan N
    Malar J; 2017 Jul; 16(1):290. PubMed ID: 28720135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAPi: Computational Model for Apicoplast Inhibitors Prediction Against Plasmodium Parasite.
    Dixit S; Singla D
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):303-310. PubMed ID: 28260517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Repurposing against Novel Therapeutic Targets in
    Rai S; Shukla S; Scotti L; Mani A
    Curr Med Chem; 2024; 31(38):6272-6287. PubMed ID: 37550911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico Screening for Identification of Novel Anti-malarial Inhibitors by Molecular Docking, Pharmacophore Modeling and Virtual Screening.
    Batool S; Khan ZA; Kamal W; Mushtaq G; Kamal MA
    Med Chem; 2015; 11(7):687-700. PubMed ID: 25741881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinoline hybrids and their antiplasmodial and antimalarial activities.
    Hu YQ; Gao C; Zhang S; Xu L; Xu Z; Feng LS; Wu X; Zhao F
    Eur J Med Chem; 2017 Oct; 139():22-47. PubMed ID: 28800458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hits, leads and drugs against malaria through diversity-oriented synthesis.
    Dandapani S; Comer E; Duvall JR; Munoz B
    Future Med Chem; 2012 Dec; 4(18):2279-94. PubMed ID: 23234551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An adaptable, fit-for-purpose screening approach with high-throughput capability to determine speed of action and stage specificity of anti-malarial compounds.
    Duffy S; Sleebs BE; Avery VM
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0074624. PubMed ID: 39264187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Targets for Malarial Chemotherapy: A Review.
    Yadav DK; Kumar S; Teli MK; Yadav R; Chaudhary S
    Curr Top Med Chem; 2019; 19(10):861-873. PubMed ID: 31161990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches in antimalarial drug discovery and development: a review.
    Aguiar AC; Rocha EM; Souza NB; França TC; Krettli AU
    Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):831-45. PubMed ID: 23147137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria.
    Hoelz LV; Calil FA; Nonato MC; Pinheiro LC; Boechat N
    Future Med Chem; 2018 Aug; 10(15):1853-1874. PubMed ID: 30019917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs.
    Tougan T; Toya Y; Uchihashi K; Horii T
    Malar J; 2019 Jan; 18(1):8. PubMed ID: 30642330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target identification and validation of novel antimalarials.
    McNamara C; Winzeler EA
    Future Microbiol; 2011 Jun; 6(6):693-704. PubMed ID: 21707315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challenges.
    Roy KK
    Int J Antimicrob Agents; 2017 Sep; 50(3):287-302. PubMed ID: 28668681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Developments in Natural Product Inspired Synthetic 1,2,4- Trioxolanes (Ozonides): An Unusual Entry into Antimalarial Chemotherapy.
    Tiwari MK; Yadav DK; Chaudhary S
    Curr Top Med Chem; 2019; 19(10):831-846. PubMed ID: 30977453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Development of Coumarin Derivatives as Potential Antiplasmodial and Antimalarial Agents.
    Hu XL; Gao C; Xu Z; Liu ML; Feng LS; Zhang GD
    Curr Top Med Chem; 2018; 18(2):114-123. PubMed ID: 29243579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.